Following the release of the House Energy and Commerce Committee’s FDA User Fees Legislative Package, the Advanced Medical Technology Association (AdvaMed) released this statement from President and CEO Scott Whitaker.
Investment in early-stage medtech innovation can be critical in ensuring that patients have access to novel therapeutics and diagnostics.
The Q1 2022 meeting focuses on the diagnostics industry with presentations from Susan Van Meter, Executive Director of AdvaMedDx and a discussion panel on deal-making in diagnostics.
Europe’s largest medtech partnering and investment conference is back in-person
Gain insights into the Small Business Innovation Research (SBIR) grant funding programs at the National Institutes of Health (NIH), the National Science Foundation (NSF), and the Department of Defense (DOD).
This interactive networking and educational event gathers medical device local and out-of-state industry experts – OEMs, contract manufacturers, suppliers, members of the investment community, and academia – for a unique…
To understand where medtech companies stand in fulfilling this objective, Deloitte and AdvaMed conducted a benchmarking analysis of data from 20 medtech company business units.
Dr. Anula Jayasuriya, an MD, PhD, and MBA from Harvard, is a leading venture capital executive focusing on investing in women’s health. Through EXXclaim Capital, a venture fund she founded…
WASHINGTON, D.C. – AdvaMed Accel – the division within AdvaMed dedicated to addressing the unique needs and challenges of smaller medical technology manufacturers – announced that Martha Shadan, executive chairwoman…